Background Dietary carbohydrate, glycemic index, and glycemic load are thought to influence colorectal cancer risk through hyperinsulinemia. We review and quantitatively summarize in a meta-analysis the evidence from prospective cohort studies. Methods We searched the PubMed database for prospective studies of carbohydrate, glycemic index, and glycemic load and colorectal cancer risk, up to October 2011. Summary relative risks were estimated by the use of a random effects model. Results We identified 14 cohort studies that could be included in the meta-analysis of carbohydrate, glycemic index, and glycemic load and colorectal cancer risk. The summary RR for high versus low intake was 1.00 (95% CI: 0.87-1.14, I 2 = 31%) for carbohydrate, 1.07 (95% CI: 0.99-1.16, I 2 = 28%) for glycemic index, and 1.00 (95% CI: 0.91-1.10, I 2 = 39%) for glycemic load. In the doseresponse analysis, the summary RR was 0.95 (95% CI: 0.84-1.07, I 2 = 58%) per 100 grams of carbohydrate per day, 1.07 (95% CI: 0.99-1.15, I 2 = 39%) per 10 glycemic index units, and 1.01 (95% CI: 0.95-1.08, I 2 = 47%) per 50 glycemic load units. Exclusion of one or two outlying studies reduced the heterogeneity, but the results were similar. Conclusion This meta-analysis of cohort studies does not support an independent association between diets high in carbohydrate, glycemic index, or glycemic load and colorectal cancer risk.
Introduction
Colorectal cancer is the third most common cancer worldwide with 1.23 million new cases diagnosed in 2008 accounting for one in ten incident cancers [1] . Ecological studies, secular trend studies, and migration studies have shown that environmental factors including lifestyle are likely to be important determinants of colorectal cancer risk [2] [3] [4] . However, although dietary factors are known to be important in colorectal cancer etiology, only intake of alcohol and red and processed meat are considered to be convincingly associated with colorectal cancer [5] .
Several lines of evidence indicate that insulin resistance may play a role in the etiology of colorectal cancer. Some risk factors for colorectal cancer including overweight and obesity, low physical activity and type 2 diabetes are linked to insulin resistance [5] [6] [7] . Epidemiological studies have reported increased colorectal cancer risk with elevated blood glucose or C-peptide [8] [9] [10] [11] [12] [13] [14] . Dietary carbohydrate intake is the main dietary component affecting an individual's insulin secretion and glycemic response [15] , but the effect varies depending on the type and amount of carbohydrate consumed. Simple carbohydrates (monosaccharides), such as glucose, fructose, and galactose, are rapidly absorbed in the small intestine without chemical breakdown and lead to a rapid increase in blood glucose levels. Disaccharides and complex carbohydrates (oligosaccharides and polysaccharides) are enzymatically broken down to monosaccharides before they are absorbed in the small intestine, and their consumption leads to a less rapid increase in blood glucose levels than monosaccharides. However, it is unknown whether different types of carbohydrates are differentially associated with colorectal cancer risk. Glycemic index (GI) is an index for ranking foods according to their effect on blood glucose concentrations and is defined as the area under the 2-h blood glucose response curve (AUC), following intake of 50 grams carbohydrate from a particular food [16] . The AUC for the test food is divided by the AUC of a reference, which is glucose or white bread, and multiplied by 100. The GI applies to foods with a reasonable carbohydrate content. Because some foods contain very little carbohydrate, one would have to eat large amounts of the food to yield 50 gram carbohydrate. Glycemic load (GL) is a ranking system for the carbohydrate content of food that takes into account the portion size (GL = (GI 9 amount of available carbohydrate)/100) [17] .
Several studies have investigated the association between diets high in carbohydrates, glycemic index, or glycemic load and colorectal cancer risk; however, the results have been inconsistent [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . A previous meta-analysis found an elevated colorectal cancer risk with a high GI and GL among case-control studies, but not among cohort studies [32] . Three large additional cohort studies have since been published on the subject [29] [30] [31] , and here, we update the evidence published up to October 2011. In addition, because to our knowledge, a meta-analysis of carbohydrate intake and colorectal cancer has not been published, we expanded the meta-analysis to include total carbohydrate and specific types of carbohydrate (excluding fiber).
Methods

Search strategy
PubMed and several other databases were used to search for studies of carbohydrate intake, glycemic index, or glycemic load and colorectal cancer risk. The literature search and data extraction up to December 2005 were conducted by several reviewers at Wageningen University. Initially, several databases were searched including PubMed, Embase, CAB Abstracts, ISI Web of Science, BIOSIS, Latin American and Caribbean Center on Health Sciences Information, Cochrane library, Cumulative Index to Nursing and Allied Health Literature, The Allied and Complementary Medicine Database, National Research Register, and In Process Medline. All the relevant prospective studies were identified by the PubMed searches, and therefore, a change in the protocol was made, and only PubMed was used for the updated searches from January 2006 to October 2011. We followed a predefined protocol for the review (http://www.dietandcancer report.org/downloads/SLR_Manual.pdf) which includes details of the search terms and standard criteria for metaanalyses of observational studies [33] . We also searched the reference lists of all the studies that were included in our analysis as well as those listed in the published systematic reviews and meta-analyses [32, 34] .
Study selection
We included prospective cohort studies, case-cohort studies, and nested case-control studies, which investigated the association between dietary carbohydrate, GI or GL and colorectal cancer risk. Estimates of the relative risk (hazard ratio, risk ratio) had to be available with the 95% confidence intervals in the publication, and for the doseresponse analysis, a quantitative measure of intake had to be provided. We identified 19 possibly relevant publications in the search [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [35] [36] [37] [38] [39] (Fig. 1) . Four of these were excluded because no risk estimates were presented [36] [37] [38] [39] . Two publications were excluded from the doseresponse analysis because they presented carbohydrate intake as a percentage of total energy intake, not in grams per day [19] or did not quantify carbohydrate intake [20] , but were included in the high versus low analysis.
Data extraction
The following data were extracted from each study: the first author's last name, publication year, country where the study was conducted, the study name, follow-up period, sample size, gender, age, number of cases, dietary assessment method (type, number of food items, and whether it had been validated), exposure, quantity of intake, RRs and 95% CIs and variables adjusted for in the analysis. The data extraction of articles published up to December 2005 was conducted by several reviewers at the Wageningen University during the systematic literature review for the WCRF/AICR 2007 report. The data extraction from January 2006 to October 2011 was conducted by three authors (DA, DSMC, and RL) and was checked for accuracy by two authors (TN and DA).
Statistical methods
Random effects models were used to calculate summary RRs and 95% CIs for the highest versus the lowest level of carbohydrate, GI, and GL intake and for the dose-response analysis [40] . The average of the natural logarithm of the RRs was estimated, and the RR from each study was weighted by the inverse of its variance. A two-tailed p \ 0.05 was considered statistically significant. For studies that reported results separately for men and women or proximal and distal colon, but not combined, we pooled the results using a fixed-effects model to obtain an overall combined estimate before combining with the rest of the studies.
The method described by Greenland and Longnecker [41] was used for the dose-response analysis, and we computed study-specific slopes (linear trends) and 95% CIs from the natural logs of the RRs and CIs across categories of carbohydrate, GI, and GL intake. The method requires that the distribution of cases and person-years or noncases and the RRs with the variance estimates for at least three quantitative exposure categories are known. The distribution of cases or person-years was estimated in studies that did not report these, but reported the total number of cases/ person-years, if the results were analyzed by quantiles (and could be approximated). For example, the total number of person-years was divided by 5 when data were analyzed by quintiles in order to derive the number of person-years in each quintile. The median or mean level of intake in each category of intake was assigned to the corresponding relative risk for each study. For studies that reported intakes by ranges, we estimated the midpoint in each category by calculating the average of the lower and upper bound. When the highest or lowest category was open-ended, we assumed the open-ended interval length to be the same as the adjacent interval. If the intakes were reported in densities (i.e., gram per 1,000 kcal), we recalculated the reported intakes to absolute intakes using the mean or median energy intake. The dose-response results in the forest plots are presented for a 10 and 50 unit increment per day for glycemic index and glycemic load, respectively, and for a 100 g per day increment for carbohydrate.
Heterogeneity between studies was assessed by the Q test and I 2 [42] , the amount of total variation that is explained by between-study variation. Subgroup and meta-regression analyses by sex, duration of follow-up, number of cases, geographic location, and adjustment for confounding factors such as body mass index, smoking, alcohol, physical activity, intake of fruit and vegetables, folate, calcium, energy and red and processed meat were conducted to investigate potential sources of heterogeneity. Publication bias was assessed with Egger's test [43] and with Begg's test [44] , and the results were considered to indicate publication bias when p \ 0.10. We conducted sensitivity analyses excluding one study at a time to investigate whether the results were due to one large study or a study with an extreme result.
Results
We identified 14 cohort studies (15 publications) [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] 35] that were included in the analysis of the highest versus the lowest carbohydrate, GI and GL intake and colorectal cancer risk, and 11 of these studies (13 publications) [18, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] 35] were included in the dose-response analysis ( Table 1 ; Fig. 1 ). One of these publications was only included in the subgroup analysis of carbohydrate intake and colon cancer [18] . Eleven studies were from NorthAmerica, two from Europe, and one from Asia.
Glycemic index
High versus low analysis
Ten cohort studies (nine publications) [22-28, 30, 31] investigated the association between glycemic index and colorectal cancer risk and included 12,382 cases among 994,154 participants. The summary RR for all studies was 1.07 (95% CI: 0.99-1.16), with no significant heterogeneity, I 2 = 28% and p heterogeneity = 0.19 ( Fig. 2a) .
Dose-response analysis
Ten cohort studies (nine publications) [22-28, 30, 31] were included in the dose-response analysis of glycemic index and colorectal cancer risk. The summary RR per 10 units per day was 1.07 (95% CI: 0.99-1.15), with some indication of heterogeneity, I 2 = 39% and p heterogeneity = 0.10 ( Fig. 2b) . The summary RR for colorectal cancer ranged from 1.04 (95% CI: 0.97-1.13) when the NIH-AARP Diet and Health Study [30] was excluded to 1.11 (95% CI: 1.05-1.17) when the Breast Cancer Detection Demonstration Project [26] was excluded and the heterogeneity was reduced to I 2 = 1% and I 2 = 20%, respectively, when each of these studies were excluded, respectively. There was no indication of publication bias with Egger's test, p = 0.34, or with Begg's test, p = 0.28.
Glycemic load
High versus low analysis
Twelve cohort studies (11 publications) [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] were included in the analysis of high versus glycemic load and colorectal cancer risk and included a total of 15,377 cases among 1,234,282 participants. The summary RR was 1.00 (95% CI: 0.91-1.10), with moderate heterogeneity, I 2 = 39%, p heterogeneity = 0.08 (Fig. 3a) .
Dose-response analysis
Twelve cohort studies (11 publications) [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] were included in the dose-response analysis. The summary RR per 50 units per day was 1.01 (95% CI: 0.95-1.08), with moderate heterogeneity, I 2 = 47%, p heterogeneity = 0.04 (Fig. 3b) . In a sensitivity analysis, the summary RR for colorectal cancer ranged from 1.00 (95% CI: 0.93-1.06) when excluding the Health Professionals Follow-up Study [23] to 1.03 (95% CI: 0.96-1.11) when excluding the NIH-AARP Diet and Health Study [30] . There was some indication of publication bias with Egger's test, p = 0.05, although not with Begg's test, p = 0.37. The heterogeneity and publication bias were largely explained by the results from the Women's Health Study [22] , which seemed to be an outlier, and when excluded, the results were similar, summary RR = 1.00 (95% CI: 0.95-1.05), but the heterogeneity was reduced, I 2 = 25%, p heterogeneity = 0.20, and Egger's test showed p = 0.21.
Carbohydrate
High versus low analysis
Twelve cohort studies (11 publications) examined [19-26, 28, 29, 31] total carbohydrate intake and colorectal cancer risk and included 9,799 cases among 806,647 participants. The summary RR was 0.93 (95% CI: 0.84-1.04) with moderate heterogeneity, I 2 = 40%, p heterogeneity = 0.08 (Fig. 4a) .
Dose-response analysis
Ten cohort studies (nine publications) [21-26, 28, 29, 31] were included in the dose-response analysis. The summary RR per 100 g/day was 0.95 (95% CI: 0.84-1.07), with moderate heterogeneity, I 2 = 58%, p heterogeneity = 0.01 (Fig. 4b) . The summary RR ranged from 0.92 (95% CI: 0.82-1.02) when excluding the Health Professionals Follow-up Study [23] to 0.97 (95% CI: 0.87-1.09) when excluding the Breast Cancer Detection Demonstration Project [26] . Exclusion of these two studies reduced the heterogeneity, I 2 = 34%, but did not materially alter the summary estimate, summary RR = 0.93 (95% CI: 0.85-1.03). There was no evidence of publication bias with Egger's test, p = 0.44, or with Begg's test, p = 0.37. 
Specific types of carbohydrate
Only six (five publications) [22-24, 29, 35] and five studies (four publications) [22] [23] [24] 35] were included in the analyses of high versus low sucrose and fructose intake and colorectal cancer, respectively. The summary RR was 1.01 (95% CI: 0.87-1.16, I 2 = 63%, p heterogeneity = 0.02) for sucrose intake (Fig. 5a ) and 1.05 (95% CI: 0.87-1.27, I 2 = 73%, p heterogeneity = 0.006) for fructose intake (Fig. 5b) . The summary RR per 25 g/d was 1.02 (95% CI: 0.93-1.13, I 2 = 70%, p heterogeneity = 0.01) for sucrose and 1.01 (95% CI: 0.91-1.12, I2 = 71%, p heterogeneity = 0.008) for fructose (results not shown). Three studies [21, 28, 35] of intake of sugars and colorectal cancer risk found no significant association, summary RR for high versus low intake = 1.01 (95% CI: 0.92-1.11, I 2 = 0%, p heterogeneity = 0.47) and per 50 g/day = 1.02 (95% CI: 0.98-1.07, I 2 = 0%, p heterogeneity = 0.70) (results not shown). Few studies had investigated other specific types of carbohydrates, thus we were not able to conduct any further analyses of these.
Subgroup, meta-regression analyses, and sensitivity analyses
In meta-regression analyses, only adjustment for physical activity was a significant predictor of heterogeneity in the analysis of glycemic index, p heterogeneity = 0.03. A significant positive association was found among studies that adjusted for physical activity (Table 2 ). In addition, a significant positive association between glycemic index and colorectal cancer was observed among men, but there was no evidence of heterogeneity between genders. There were no significant predictors of heterogeneity in subgroup analyses of glycemic load or carbohydrate, although for carbohydrate, there was borderline evidence of a positive association among men, but not among women, p heterogeneity = 0.06.
In a sensitivity analysis, we stratified the results by whether they used glucose or white bread as a reference for the calculation of GI and GL. The summary RR per 10 GI units per day was 1.06 (95% CI: 0.92-1.22, I 2 = 62%) for the six studies [22, 26-28, 30, 31] using glucose as the reference and 1.07 (95% CI: 0.99-1.16, I 2 = 0%) for the four studies [23] [24] [25] using white bread as the reference, with no between subgroup heterogeneity, p = 0.98. The summary RR per 50 GL units per day was 0.98 (95% CI: 0.98-1.06, I 2 = 46%) for seven studies [22, [26] [27] [28] [29] [30] [31] using glucose as the reference, while it was 1.11 (95% CI: 1.01-1.22, I 2 = 0%) for four studies [23] [24] [25] using white bread as a reference, although there was no between subgroup heterogeneity, [21] it was unclear what was used as the reference).
In a sensitivity analysis, we included one study in the dose-response analysis that reported carbohydrate intake as a percentage of energy intake, by recalculating the intake to grams using the mean energy intake among noncases [19] . The summary RR was 0.94 (95% CI: 0.85-1.05, I 2 = 55%, p heterogeneity = 0.02).
Discussion
We found no statistically significant association between dietary carbohydrate, sucrose, fructose, sugars, glycemic index, or glycemic load and colorectal cancer risk in categorical and dose-response meta-analyses. In the analysis of carbohydrate, glycemic index, and glycemic load and colorectal cancer, there was significant Glycemic index, dose-response per 10 units/d B Fig. 2 Glycemic index and colorectal cancer heterogeneity that was largely explained by one or two outlying studies.
Although case-control studies have provided some evidence of a positive association between glycemic index and glycemic load and colorectal cancer [32, 34] , these studies may be prone to selection and recall biases that can make it difficult to draw firm conclusions. Our results, which are based on prospective studies, are not prone to recall bias, because diet is assessed before the development of disease, and in addition, selection bias is less likely to have influenced these results.
Our meta-analysis may have several limitations that must be taken into consideration. Intake of diets rich in carbohydrate and high in GI and GL may be associated with other behaviors including physical inactivity, overweight and obesity, smoking, high intake of alcohol and red and processed meats. The association between intake of carbohydrate, GI, and GL and the confounding factors may 
differ between studies and populations [22, 25, 30, 31] . However, we generally did not find evidence of significant heterogeneity between subgroups in our analyses. In stratified analyses and meta-regression analyses, only one subgroup analysis showed significant heterogeneity between studies that adjusted or did not adjust for confounders.
There was a significant positive association between glycemic index and colorectal cancer in studies that adjusted for physical activity, but a nonsignificant inverse association among studies that did not adjust for physical activity.
In addition, there was a positive association between glycemic index and colorectal cancer in the three studies of men, but not in the nine studies among women, although no significant between gender heterogeneity in the results was detected. Due to the numerous comparisons and the few studies in this subgroup, these findings may have been due to chance, but further studies are warranted. We found no statistical evidence of publication bias in this analysis, but we may have had limited power to detect such bias due to the limited number of studies. Measurement errors in the assessment of dietary intake are known to bias effect estimates; however, none of the studies included in this meta-analysis made any corrections for measurement errors. Assessment of GI or GL may in this respect be particularly challenging, because these measures are based on their postprandial blood glucose response and are not concentration values of nutrients in the foods consumed. Most dietary questionnaires have estimated usual GI or GL values based on a limited number of food items, which may not have been specifically selected and validated for dietary GI or GL. However, when we analysed total carbohydrate intake we found similarly to the analyses of GI and GL no significant association. In addition, the studies that have evaluated the association between glycemic index, glycemic load or carbohydrate intakes and colorectal adenomas found no evidence of an increased risk [45] [46] [47] [48] [49] [50] [51] [52] , and some even a suggestive inverse association [45, [49] [50] [51] [52] . Studies using 
All studies similar questionnaires have been able to detect associations between GI, GL and risk of type 2 diabetes [53] and cardiovascular disease [54] , but nevertheless we cannot exclude the possibility that a more modest or weak association with colorectal cancer may have been missed due to measurement errors. One of the main mechanisms that has been proposed to explain a possible association between carbohydrate intake, GI and GL and cancer risk involves hyperinsulinemia, which increases the bioactivity of insulin-like growth factor 1 [55] , which in turn may stimulate tumor development by inhibiting apoptosis and stimulate cell proliferation [56] . However, dietary fat and protein intake also stimulates insulin secretion [57] , thus only assessing the influence of carbohydrate intake on blood glucose (such as with glycemic index and glycemic load) may have limited the ability to detect an association with cancer if it was due to hyperinsulinemia. An insulin index that quantifies the postprandial insulin response for various food items has been proposed as a better tool for investigating the insulin hypothesis [58, 59] . However, the only study that has investigated the association between a dietary insulin index or insulin load and colorectal cancer found no significant association [59] . In addition, some foods high in carbohydrate, such as fruits and vegetables and grains, contain other bioactive components that may reduce colorectal cancer risk [60, 61] . This may have offset any adverse effects that might be due to their carbohydrate content alone or may have diluted any adverse effects that may have been due to single food items and might explain the lack of an association between carbohydrate intake and colorectal cancer risk.
Our meta-analysis also has several strengths. Because we based our analyses on prospective studies, we have effectively avoided recall and selection bias. The studies included a larger number of cases and participants than any previous meta-analysis on the topic that we are aware of, with a total of approximately 0.8-1.2 million participants and &9,800-15,000 cases. Thus, we had statistical power to detect moderate associations. Although we cannot exclude the possibility that a very weak association with a high GI may have been obscured due to measurement errors, our study, with an even larger sample size than available previously, does not provide support for the hypothesis that intake of diets high in carbohydrate, GI, or GL is strongly associated with colorectal cancer risk.
In conclusion, our results do not support the hypothesis that dietary carbohydrate, GI, or GL are associated with colorectal cancer risk. However, further studies among men and with adjustment for more confounding factors could clarify whether there is a gender-specific association between glycemic index or carbohydrate intake and colorectal cancer risk. 
